IFNG and colon carcinoma: To test this hypothesis, the TRAIL-resistant metastatic human colon carcinoma SW620 cells were pre-treated with recombinant TNFα, IFN-γ or both TNFα and IFN-γ, and tested their sensitivity to TRAIL-induced apoptosis.